Author:
Peters Solange,Curioni-Fontecedro Alessandra,Nechushtan Hovav,Shih Jin-Yuan,Liao Wei-Yu,Gautschi Oliver,Spataro Vito,Unk Mojca,Yang James Chih-Hsin,Lorence Robert M.,Carrière Philippe,Cseh Agnieszka,Chang Gee-Chen
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference36 articles.
1. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014
2. Targeted therapies in non–small cell lung cancer-beyond EGFR and ALK;Rothschild;Cancers (Basel),2015
3. US Food and Drug Administration. TAFINLAR. Highlights of prescribing information. 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202806s006lbl.pdf. Accessed March 19, 2018.
4. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas;Shigematsu;Cancer Res,2005
5. Targeted therapy in NSCLC driven by HER2 insertions;Peters;Transl Lung Cancer Res,2014
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献